You are here: Welcome to the MPKB » Welcome to the MPKB » Diseases » Anxiety
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Next revisionBoth sides next revision
home:diseases:anxiety [03.16.2012] – [Patients experiences] paulalberthome:diseases:anxiety [03.11.2019] – [Management of symptoms] sallieq
Line 7: Line 7:
 Anxiety or anxiety disorder is a common co-morbidity of patients sufferings from chronic inflammatory diseases. Like all inflammatory diseases, anxiety disorder is caused by the Th1 pathogens and may temporarily increase during periods of immunopathology. Cognitive dysfunction can be managed using the [[home:mp:managing_immunopathology|generic strategies for managing immunopathology]], and should resolve over the course of the Marshall Protocol (MP). Anxiety or anxiety disorder is a common co-morbidity of patients sufferings from chronic inflammatory diseases. Like all inflammatory diseases, anxiety disorder is caused by the Th1 pathogens and may temporarily increase during periods of immunopathology. Cognitive dysfunction can be managed using the [[home:mp:managing_immunopathology|generic strategies for managing immunopathology]], and should resolve over the course of the Marshall Protocol (MP).
  
-Anxiety can be subtle or debilitating or both. Some patients may not possess the presence of mind to know they're suffering from anxiety. It often does not occur to Marshall Protocol (MP) patients, even in the midst of severe anxiety, that their emotional state is a product of the disease process. +Anxiety can be subtle or debilitating or both. Some patients may not possess the presence of mind to know they're suffering from anxiety. It often does not occur to Marshall Protocol (MP) patients, even in the midst of severe anxiety, that their emotional state may be a product of the disease process. 
  
 Patients suffering from anxiety may wish to modify their dose of antibiotics or take an [[home:othertreatments:antidepressants|anti-anxiety agent]]. Patients suffering from anxiety may wish to modify their dose of antibiotics or take an [[home:othertreatments:antidepressants|anti-anxiety agent]].
Line 18: Line 18:
 //**L.E. Goehler** et al.//(({{pubmed>long:17428636}}))</blockquote> //**L.E. Goehler** et al.//(({{pubmed>long:17428636}}))</blockquote>
  
-Further, Neufeld //et al.// showed that germ-free mice exhibited reduced anxiety-like behavior as well as significant neurochemical changes in the brain compared to mice without an intestinal microbiota.(({{pubmed>long:21054680}}))+Further, Neufeld //et al.// showed that germ-free mice exhibited reduced anxiety-like behavior as well as significant neurochemical changes in the brain compared to specific-pathogen-free mice. (({{pubmed>long:21054680}}))
  
  
Line 37: Line 37:
 Anxiety can and should be managed just like other symptoms. The following strategies and therapies may limit or help manage the anxiety a patient experiences Anxiety can and should be managed just like other symptoms. The following strategies and therapies may limit or help manage the anxiety a patient experiences
   * Restrict light exposure. It is very common for MP patients to experience anxiety in the hours or days following light exposure.   * Restrict light exposure. It is very common for MP patients to experience anxiety in the hours or days following light exposure.
-  * Modify doses of antibiotics.+  * Modify doses of antibiotics, if used.
   * Take an [[home:othertreatments:antidepressants|anti-anxiety agent]].   * Take an [[home:othertreatments:antidepressants|anti-anxiety agent]].
   * Practice good sleep hygiene.   * Practice good sleep hygiene.
home/diseases/anxiety.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.